Pricing

Log inSign up

QuellTX

4 followers

‌

Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading... Read more

Industries

Biotechnology, Education

Headquarters

London, United Kingdom

Employees

51-200

Links

Org chart

Jodie Albutt
VP, IP
Julien Browne
Associate Director Head Analytical Development
Laura Fry
Head of Cell Processing
Luke Devey
Chief Medical Officer
Luke Henry, PhD
Chief Business Officer
Lyndsay Telakis FCIPD
Vice President, People & Culture
Marc Martinez-Llordella
Co-founder & VP Biology
PC
Paul S Carter
Senior Director MSAT
Chris Sharpe
VP, Regulatory Affairs
Aaron Vernon
Chief Manufacturing Officer
Parveen Kaley
Executive Management Assistant - Chief Manufacturing Officer (cmo) / Deputy EA To Ceo.

Teams

+41

Research and Development

44 members

+18

Operations and Management

21 members

+6

Leadership Team

9 members

Similar companies

Poppi

9 followers

FutureLearn

1 follower

LeapFrog Investments

3 followers

Wheely

2 followers

Jnana Therapeutics

1 follower

Sonoma Biotherapeutics

1 follower

Edinburgh College

5 followers

4D Molecular Therapeutics

3 followers

Global University Systems

2 followers

EvolvedMD

3 followers

Pivot Bio

2 followers

Explore companies